KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dynavax Technologies (DVAX) Free Cash Flow: 2009-2025

Historic Free Cash Flow for Dynavax Technologies (DVAX) over the last 15 years, with Sep 2025 value amounting to $32.6 million.

  • Dynavax Technologies' Free Cash Flow rose 79.86% to $32.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $80.5 million, marking a year-over-year increase of 255.26%. This contributed to the annual value of $60.2 million for FY2024, which is 37.63% down from last year.
  • Dynavax Technologies' Free Cash Flow amounted to $32.6 million in Q3 2025, which was up 48.29% from $22.0 million recorded in Q2 2025.
  • Over the past 5 years, Dynavax Technologies' Free Cash Flow peaked at $117.5 million during Q4 2021, and registered a low of -$52.5 million during Q1 2022.
  • Over the past 3 years, Dynavax Technologies' median Free Cash Flow value was $22.0 million (recorded in 2025), while the average stood at $17.1 million.
  • In the last 5 years, Dynavax Technologies' Free Cash Flow soared by 811.37% in 2021 and then slumped by 244.55% in 2022.
  • Over the past 5 years, Dynavax Technologies' Free Cash Flow (Quarterly) stood at $117.5 million in 2021, then plummeted by 71.60% to $33.4 million in 2022, then tumbled by 63.90% to $12.0 million in 2023, then skyrocketed by 311.30% to $49.5 million in 2024, then soared by 79.86% to $32.6 million in 2025.
  • Its last three reported values are $32.6 million in Q3 2025, $22.0 million for Q2 2025, and -$23.6 million during Q1 2025.